Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients

CONCLUSIONS: Prophylaxis with antiviral medications reduces CMV disease and CMV-associated death, compared with placebo or no treatment, in solid organ transplant recipients. These data support the continued routine use of antiviral prophylaxis in CMV-positive recipients and CMV-negative recipients of CMV-positive organ transplants.PMID:38700045 | DOI:10.1002/14651858.CD003774.pub5

Source: Cochrane Database of Systematic Reviews - May 3, 2024 Category: General Medicine Authors: Robin Wm Vernooij Mini Michael Maleeka Ladhani Angela C Webster Giovanni Fm Strippoli Jonathan C Craig Elisabeth M Hodson Source Type: research